Latest news
Did Novo’s phase 3 flop kill the inflammation hypothesis in heart disease? - Pharma VoicePharma Voice · Mon, 10 Aug 2026 13:30:27 GMTThe Presidents of the Estado Novo - Portugal ResidentPortugal Resident · Sun, 09 Aug 2026 16:35:42 GMTThe Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 07:00:00 GMTNovo Nordisk’s Wegovy Pill Is Winning Back Share by Undercutting Novo Nordisk - Business Model AnalystBusiness Model Analyst · Thu, 06 Aug 2026 13:05:01 GMTNovo fails to shrug off investor concern at Q2 update - pharmaphorumpharmaphorum · Wed, 05 Aug 2026 10:41:51 GMTNovo CEO Faces Investor Scrutiny Over Pipeline and Growth Outlook - Global Banking & Finance ReviewGlobal Banking & Finance Review · Wed, 05 Aug 2026 08:46:10 GMTNovo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline - CNBCCNBC · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk's Ziltivekimab Fails to Reduce Cardiovascular Events in Phase 3 ZEUS Trial - BioPharm InternationalBioPharm International · Fri, 31 Jul 2026 07:00:00 GMT